Eisai Co., Ltd. - Lemborexant and Novel Orexin Receptor Agonist E2086 World Sleep 2025
Seeking Alphaยท2025-09-11 08:55
PresentationUnknown Executive Thank you very much for taking your time. We would now like to begin oral presentation of highlight of E2086 from World Sleep 2025 oral presentation. This is a virtual session. Please check our website for presentation material. In Singapore this week, World Sleep 2025 was held. E2086 Phase I study results were presented in oral presentation. The highlight of the presentation will be given today, and questions will also be taken to deepen understanding of the audience of E2086. ...